TY  - JOUR
T1  - NIh program to boost pipeline for drugs to treat rare and neglected diseases
AU  - Kuehn BM
Y1  - 2009/07/08
N1  - 10.1001/jama.2009.940
JO  - JAMA
SP  - 133
EP  - 134
VL  - 302
IS  - 2
N2  - 
The program, called Therapeutics for Rare and Neglected Diseases (TRND), marks the agency's largest foray into developing drugs. It will bring together expertise from various sectors of the NIH—including the Office of Rare Diseases Research (ORDR), the National Human Genome Research Institute, and the NIH Chemical Genomics Center (NCGC)—as well as expertise from outside researchers and organizations. TRND's focus will be moving candidate molecules through the preclinical phase of development and then licensing the candidates to other entities for further development. 

SN  - 0098-7484
M3  - doi: 10.1001/jama.2009.940
UR  - http://dx.doi.org/10.1001/jama.2009.940
ER  -